about
Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinomaTargeting angiogenesis in squamous non-small cell lung cancerCurrent and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptorsC4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaPulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancerAnalysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancerCeritinib for treatment of ALK-rearranged advanced non-small-cell lung cancer.Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy.A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
P2860
Q26767182-35200C66-7382-4919-BFB8-E1384C5ABDA4Q26861341-309FD4C7-A9F8-4989-B55C-EB924316C805Q28086768-D075F1CF-35FF-4450-81C3-4C5C738BD97DQ34031219-65ED26B3-87AC-425E-AAE8-DF04F4473406Q34404209-CE94AD7F-68CC-4F7B-90F0-DBBFCD1DF6DFQ34786471-9A319489-B863-467C-80B8-108EAFD6FD5DQ36834504-EE64F78A-D448-400D-9B6A-A26AB1DE1D32Q38214154-CCD04A20-F4C0-4FA4-976A-F0E29D3ACB4EQ38729384-ACE9399B-9D6D-44EB-940B-4408226019E0Q38854471-9409C559-1838-410D-9F09-33494C7B5CEBQ38981486-A1B6632B-DB71-46C6-B7A8-55C8252039B0Q39172334-1F98C53F-3DD2-4862-AFC6-AD2323DD502CQ42290335-5E3D0E48-E44A-436B-BF2D-8B3AED04A0DAQ48097759-CC1389F2-E875-4A1A-87BC-638B015F23B7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted therapy for NSCLC with driver mutations.
@en
type
label
Targeted therapy for NSCLC with driver mutations.
@en
prefLabel
Targeted therapy for NSCLC with driver mutations.
@en
P2860
P1476
Targeted therapy for NSCLC with driver mutations.
@en
P2093
Armida D'Incecco
Gabriele Minuti
P2860
P304
P356
10.1517/14712598.2013.827657
P407
P577
2013-08-10T00:00:00Z